SCHEMBL32688239

SCHEMBL32688239

CCOC(=O)CC(=O)c1cccc(N2CCN(c3ccccc3)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLOD2 O00469 3/20 0.53
PLOD3 O60568 3/20 0.53
PLOD1 Q02809 3/20 0.53
TSHR P16473 4/20 0.48
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
LMNA P02545 2/20 0.48
MAPK1 P28482 2/20 0.48
USP2 O75604 1/20 0.48
ATM Q13315 1/20 0.47
KMO O15229 1/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GAA P10253 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CASP1 P29466 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688293 0.91 PLOD2 (0.65) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL32688378 0.91 ALDH1A1 (0.55) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL32688300 0.90 ALDH1A1 (0.54) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL32688024 0.89 PLOD2 (0.50) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL32688003 0.84 GPR119 (0.52) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL124577 0.79 KMT2A (0.59) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL32688044 0.78 MEN1 (0.61) TSHRALDH1A1MAPTLMNAUSP2
SCHEMBL32688049 0.78 ERCC5 (0.60) ALDH1A1MAPTKMOKDM4EMEN1
SCHEMBL5869170 0.78 LMNA (0.45) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL28692105 0.78 PLOD2 (0.67) PLOD2PLOD3PLOD1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK PLOD2 1971/4885PLOD3 1667/4885PLOD1 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.